Mobile Menu - OpenMobile Menu - Closed

Cancer Research

 


Over 100 years ago Western New York gave modern cancer research to the world through what would become the Roswell Park Cancer Institute. Today our region continues to lead the way in medical and scientific research. As a Member of the House Cancer Caucus, Brian has been a steadfast supporter for cancer research, both for local researchers and for the nation’s cancer program generally. Brian has led efforts among his colleagues to increase funding for cancer research and is engaged with the cancer community on innovations that will alleviate suffering due to cancer and ultimately find a cure. Brian has introduced H.R. 1801, the Cancer Drug Coverage Parity Act, which would require health insurance companies to provide the same coverage for new, promising orally-administered anti-cancer medication as it does for traditional intravenous chemotherapy. 

 

More on Cancer Research

Oct 10, 2014 Press Release

BUFFALO, N.Y. — The National Cancer Institute has awarded Roswell Park Cancer Institute (RPCI) a new one-year, $150,000 supplemental grant as part of an effort to increase the number of adolescents — both girls and boys —receiving the HPV vaccine. The three-dose vaccine protects against infection with certain high-risk strains of human papillomavirus (HPV) that are responsible for most cases of cervical and anal cancers as well as many genital and head/neck cancers.

Sep 22, 2014 Press Release

Congressman Brian Higgins joined Congresswoman Rosa DeLauro in introducing H.R. 5580, the Accelerating Biomedical Research Act.  This legislation will incrementally increase funding for the National Institutes of Health (NIH) over the next seven years.  The DeLauro-Higgins bill is the House companion of S. 2658 introduced by Senator Harkin, a longstanding champion of NIH funding.  

Sep 12, 2014 Press Release

 

 

(To access video click above or go to: https://youtu.be/JEy1syNFLqo)

 

Jul 1, 2014 Press Release

The National Cancer Institute (NCI) has renewed the coveted and prestigious Cancer Center Support Grant (CCSG) to Roswell Park Cancer Institute (RPCI) following an in-depth peer review by cancer experts from around the United States.

Jun 12, 2014 Press Release

U.S. Senator Kirsten Gillibrand and Congressman Brian Higgins (NY-26) today announced $280,332 in 2014 funding for Roswell Park Cancer Institute’s (RPCI) Summer Research Experience Programs in Cancer Sciences and Oncology in Buffalo. This federal funding, part of a five-year, $1.4 million allocation, will be used to engage college and medical school students in research and clinical internships.
 

May 13, 2014 Press Release

Congresswoman Debbie Wasserman Schultz (FL-23) and Congressman Brian Higgins (NY-26) recognized National Women’s Health Week with a tour of Roswell Park Cancer Institute’s (RPCI) Center for Personalized Medicine and a discussion about the future of cancer treatment and prevention. 

Apr 10, 2014 Press Release

Congressman Brian Higgins (NY-26) announced that Roswell Park Cancer Institute has been awarded $406,247 in grant funding from the National Cancer Institute.  The two year federal grant will provide $221,589 toward the project in the first year and $184,658 the following year. 

Mar 27, 2014 Press Release

Congressman Brian Higgins (NY-26), a member of the House Cancer Caucus, spoke on the House Floor to recognize National Multiple Myeloma Awareness Month and to advocate for increased funding for medical research and passage of H.R. 1801, the Cancer Drug Coverage Parity Act.

Feb 4, 2014 Press Release
Congressman Brian Higgins (NY-26) took to the Floor of the House of Representatives to recognize February 4, 2014 as World Cancer Day, a time to raise awareness about the impacts of cancer worldwide and to come together to work toward a cure.
Nov 19, 2013 Press Release
Congressman Brian Higgins (NY-26) spoke from the Floor of the House of Representatives to advocate for orally-administered chemotherapy drugs to be covered by insurance companies at an equal cost to more traditional intravenous chemotherapy drugs.

Pages